Michael Rink

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

Évanguelos Xylinas, Michael Rink, Thomas Clozel et al. · European Urology · 2012 · 258 citations

Medicine, Surgery, Urology +16

64-slice multidetector coronary CT angiography: in vitro evaluation of 68 different stents

David Maintz, Harald Seifarth, Rainer Raupach et al. · European Radiology · 2005 · 224 citations

Medicine, Cardiology, Radiology +16

Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort

Atiqullah Aziz, Matthias May, Maximilian Burger et al. · European Urology · 2014 · 206 citations

Medicine, Surgery, Urology +14

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt et al. · European Urology · 2019 · 192 citations · Full text

Medicine, Oncology, Urology +16